α-Melanocyte stimulating hormone in critically injured trauma patients

Journal of Trauma - Injury, Infection and Critical Care

Volumn 66, Issue 2, 2009, Pages 465-469

  Todd, S Rob ^a   Kao, Lillian S ^b   Catania, Anna ^c   Mercer, David W ^b   Adams, Sasha D ^b   Moore, Frederick A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

MSH; Alpha melanocyte stimulating hormone; Critically injured trauma patients

Indexed keywords

ALPHA INTERMEDIN;

ADULT; ARTICLE; BLUNT TRAUMA; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DEATH; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; PRIORITY JOURNAL; RESUSCITATION; TRUNK; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CRITICAL ILLNESS; INCIDENCE; INJURY SCALE; MIDDLE AGED; MORTALITY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; STATISTICS;

ADULT; ALPHA-MSH; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CRITICAL ILLNESS; FEMALE; HUMANS; INCIDENCE; INJURY SEVERITY SCORE; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MULTIPLE TRAUMA; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 67651149706     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e31818b1e04     Document Type: Article

References (25)

1. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24:1125.
2. Yao YM, Redl H, Bahrami S, Schlag G. The inflammatory basis of trauma/shock-associated multiple organ failure. Inflamm Res. 1998;47:201. (Pubitemid 28256968)
3. Neidhardt R, Keel M, Steckholzer U, et al. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma. 1997;42:863. (Pubitemid 27258317)
4. Keel M, Trentz O. Pathophysiology of polytrauma. Injury. 2005;36:691.
5. Lyons A, Kelly JL, Rodrick ML, Mannick JA, Lederer JA. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg. 1997;226:450. (Pubitemid 28049667)
6. Malone DL, Kuhls D, Napolitano LM, McCarter R, Scalea T. Back to basics: validation of the admission systemic inflammatory response syndrome score in predicting outcome in trauma. J Trauma. 2001;51:458. (Pubitemid 33009628)
7. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995;273:117.
8. Van Griensen M, Krettek C, Pape HC. Immune reactions after trauma. Eur J Trauma. 2003;29:181.
9. Schroder O, Laun RA, Held B, Ekkernkamp A, Schulte KM. Association of interleukin-10 promoter polymorphism with the incidence of multiple organ dysfunction following major trauma: results of a prospective pilot study. Shock. 2004;21:306.
10. Catania A, Airaghi L, Garofalo L, Cutuli M, Lipton JM. The neuropeptide α-MSH in HIV infection and other disorders in humans. Ann NY Acad Sci. 1998;840:848. (Pubitemid 28302109)
11. Catania A, Airaghi L, Manfredi MG, et al. Proopiomelanocortin-derived peptides and cytokines: Relations in patients with acquired immunodeficiency syndrome. Clin Immunol Immunopathol. 1993;66:73. (Pubitemid 23069258)
12. Catania A, Manfredi MG, Airaghi L, et al. Plasma concentrations of cytokine antagonists in patients with HIV infection. Neuroimmunomodulation. 1994;1:42.
13. Catania A, Gerloni V, Procaccia S, et al. The anticytokine neuropeptide α-melanocyte-stimulating hormone in synovial fluid of patients with rheumatic diseases: comparisons with other anticytokine molecules. Neuroimmunomodulation. 1994;1:321.
14. Airaghi L, Lettino M, Manfredi MG, Lipton JM, Catania A. Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy. Am Heart J. 1995;130:204.
15. Catania A. The neuropeptide α-MSH in multiple sclerosis. Second research project on multiple sclerosis. Rapporti ISTISAN. 18:56.
16. Airaghi L, Garofalo L, Cutuli MG, et al. Plasma concentrations of α-melanocyte-stimulating hormone are elevated in patients on chronic hemodialysis. Nephrol Dial Transplant. 2000;15:1212. (Pubitemid 30487800)
17. Magnoni S, Stocchetti N, Colombo G, et al. α-melanocyte stimulating hormone is decreased in plasma of patients with acute brain injury. J Neurotrauma. 2003;20:251. (Pubitemid 36373822)
18. Catania A, Cutuli M, Garofalo L, et al. Plasma concentrations and anti-L-cytokine effects of α-melanocyte stimulating hormone in septic patients. Crit Care Med. 2000;28:1403. (Pubitemid 30324514)
19. Marr AB, Moore FA, Sailors RM, et al. 'Starling curve' generation during shock resuscitation: can it be done? Shock. 2004;21:300.
20. 2 delivery goals in shock resuscitation: the response is the same. J Trauma. 2002;53:825.
21. McKinley BA, Sailors RM, Glorsky SL, et al. Computer directed resuscitation of major torso trauma. Shock. 2001;15(suppl):46.
22. Catania A, Airaghi L, Colombo G, Lipton JM. α-melanocyte- stimulating hormone in normal human physiology and disease states. Trends Endocrinol Metab. 2000;11:304. (Pubitemid 30728999)
23. Sauaia A, Moore FA, Moore EE, Haenel JB, Read RA, Lezotte DC. Early predictors of postinjury multiple organ failure. Arch Surg. 1994;129:39. (Pubitemid 24024516)
24. Ichiyama T, Sato S, Okada K, Catania A, Lipton JM. The neuroimmunomodulatory peptide α-MSH. Ann NY Acad Sci. 2000;917:221.
25. Bell RC, Lipton JM. Concentration of melanocyte stimulating hormone (MSH) within specific brain regions in aged squirrel monkeys. Brain Res Bull. 1987;18:577.